Zobrazeno 1 - 10
of 184
pro vyhledávání: '"WALTER KISIEL"'
Autor:
Walter Kisiel
Publikováno v:
Handbook of Natural Toxins ISBN: 9780203752715
Handbook of Natural Toxins
Handbook of Natural Toxins
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bcdc0d34bad2eba376a8da05270e85d3
https://doi.org/10.1201/9780203752715-8
https://doi.org/10.1201/9780203752715-8
Autor:
Yang J. Lu, John M. Ndungu, Terry W. Moore, Daniel J. Brat, Aiming Sun, Ernest T. Parker, Walter Kisiel, Mamoru Shoji, Bassel F. El-Rayes, Dennis C. Liotta, Lars Christian Petersen, Shijun Zhu, James P. Snyder
Publikováno v:
Journal of Drug Delivery
Journal of Drug Delivery, Vol 2014 (2014)
Journal of Drug Delivery, Vol 2014 (2014)
Breast cancer aberrantly expresses tissue factor (TF) in cancer tissues and cancer vascular endothelial cells (VECs). TF plays a central role in cancer angiogenesis, growth, and metastasis and, as such, is a target for therapy and drug delivery. TF i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::330700240c2156d8d64979104ee6a6e4
https://doi.org/10.1155/2014/865732
https://doi.org/10.1155/2014/865732
Autor:
Marek Z, Wojtukiewicz, Dominika, Hempel, Joanna, Kruszewska, Lech, Zimnoch, Walter, Kisiel, Ewa, Sierko
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 20(6)
Erythropoiesis-stimulating agents (ESAs) are recommended for treating chemotherapy-induced anemia in breast cancer patients. Reduced survival rates in ESAs-treated patients have been reported, possibly due to thromboembolic complications, however the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3ca74743e4582447043ca4da3f2d82c5
https://pubmed.ncbi.nlm.nih.gov/26854437
https://pubmed.ncbi.nlm.nih.gov/26854437
Autor:
Lech Zimnoch, Piotr Tokajuk, Krystyna Ostrowska-Cichocka, Marek Z. Wojtukiewicz, Rodryg Ramlau, Ewa Sierko, Walter Kisiel
Publikováno v:
Thrombosis Research. 129:e92-e96
Introduction NSCLC progression is often associated with VTE. Activation of factor X is an important step in blood coagulation activation in cancer patients. PZ)/ZPI contribute to direct factor Xa inhibition, and ZPI - attenuates factors IXa and XIa a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53005a474388c4a08fe40096b23320cf
https://doi.org/10.1016/j.thromres.2011.09.005
https://doi.org/10.1016/j.thromres.2011.09.005
Autor:
Walter Kisiel, Piotr Tokajuk, Lech Zimnoch, Ewa Sierko, Marek Z. Wojtukiewicz, Krystyna Ostrowska-Cichocka
Publikováno v:
Thrombosis Research. 129:e112-e118
Introduction Several hemostatic system components, including factor X (FX), contribute to cancer progression. The Protein Z (PZ)/protein Z-dependent protease inhibitor (ZPI) complex directly inhibits factor Xa proteolytic activity. The aim of this st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::475ca1dbd787c48be5ed6e6143f56458
https://doi.org/10.1016/j.thromres.2011.10.027
https://doi.org/10.1016/j.thromres.2011.10.027
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 331:940-945
Bovine aprotinin, a reversible inhibitor of plasmin and kallikrein, has been clinically approved for over two decades to prevent perioperative blood loss during cardiac surgery. However, because of postoperative renal dysfunction in thousands of thes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c75484a77ddcf963a080bc230446f17f
https://doi.org/10.1124/jpet.109.161034
https://doi.org/10.1124/jpet.109.161034
Autor:
Walter Kisiel
Publikováno v:
Journal of Thrombosis and Haemostasis. 7:1053-1056
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a1399c13da542f2e918a74ff2277135
https://doi.org/10.1111/j.1538-7836.2009.03450.x
https://doi.org/10.1111/j.1538-7836.2009.03450.x
Autor:
Prakasha Kempaiah, Walter Kisiel
Publikováno v:
Apoptosis. 13:702-715
Human TFPI-2 is an extracellular matrix-associated Kunitz-type serine proteinase inhibitor. We previously demonstrated that a human fibrosarcoma cell line, HT-1080, does not express TFPI-2, but genetic restoration of TFPI-2 expression in these cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58605e8a800b5ef977736a05c7ac1c1e
https://doi.org/10.1007/s10495-008-0207-8
https://doi.org/10.1007/s10495-008-0207-8
Publikováno v:
British Journal of Haematology. 63:309-320
Summary. In this report cultured bovine capillary endothelial cells are demonstrated to specifically bind factors IX and X and also their activated forms. Bound factor IXa and cell-associated factor VIII can activate factor X. The product of this rea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b8f058a1d0f83f21add3cf5ac2c97c2
https://doi.org/10.1111/j.1365-2141.1986.tb05554.x
https://doi.org/10.1111/j.1365-2141.1986.tb05554.x
Targeting tissue factor-expressing tumor angiogenesis and tumors with EF24 conjugated to factor VIIa
Autor:
Christopher E. Nichols, James P. Snyder, Jan Pohl, Aiming Sun, Mamoru Shoji, Walter Kisiel, Yang J. Lu, Hyunsuk Shim, Bernard E. McCarey, Dennis C. Liotta, Aaron R. Alizadeh, Ernest T. Parker, Cara Mosley
Publikováno v:
Journal of Drug Targeting. 16:185-197
Tissue factor (TF) is aberrantly expressed on tumor vascular endothelial cells (VECs) and on cancer cells in many malignant tumors, but not on normal VECs, making it a promising target for cancer therapy. As a transmembrane receptor for coagulation f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::becacc13022ac2ff00bbcc866d08b183
https://doi.org/10.1080/10611860801890093
https://doi.org/10.1080/10611860801890093